American Vietnamese Biotech (HSTC:AMV) Marketable Securities: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is American Vietnamese Biotech Marketable Securities?

American Vietnamese Biotech HSTC:AMV -7.14% Marketable Securities is ₫0.00 Mil as of . 20.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. American Vietnamese Biotech's Marketable Securities for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech  (HSTC:AMV) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

American Vietnamese Biotech Marketable Securities Related Terms

American Vietnamese Biotech Marketable Securities Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Marketable Securities Chart

American Vietnamese Biotech Annual Data
Trend
Marketable Securities

American Vietnamese Biotech Quarterly Data
Marketable Securities

American Vietnamese Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₫0.00 Mil mean?
American Vietnamese Biotech (HSTC:AMV) has a Marketable Securities of ₫0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Marketable Securities too high?
American Vietnamese Biotech's current Marketable Securities is ₫0.00 Mil.
How does American Vietnamese Biotech's Marketable Securities compare to HSTC and STLT?
American Vietnamese Biotech's Marketable Securities of ₫0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Marketable Securities is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Marketable Securities of ₫0.00 Mil. The current Marketable Securities is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Marketable Securities is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.